Press coverage about Markel (NYSE:MKL) has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Markel earned a news sentiment score of 0.18 on Accern’s scale. Accern also assigned headlines about the insurance provider an impact score of 46.1327475133069 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:

MKL has been the subject of several research analyst reports. SunTrust Banks reissued a “hold” rating and set a $1,100.00 price objective on shares of Markel in a research note on Friday, October 27th. Royal Bank of Canada reissued a “hold” rating and set a $1,200.00 price objective on shares of Markel in a research note on Thursday, February 8th. Zacks Investment Research lowered Markel from a “buy” rating to a “hold” rating in a research note on Thursday, January 11th. Finally, Boenning Scattergood reissued a “buy” rating on shares of Markel in a research note on Thursday, October 26th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $1,172.00.

Shares of Markel (MKL) traded up $9.20 during mid-day trading on Tuesday, reaching $1,097.52. The company’s stock had a trading volume of 25,436 shares, compared to its average volume of 42,642. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.55 and a current ratio of 0.55. Markel has a 52-week low of $936.95 and a 52-week high of $1,157.30. The company has a market capitalization of $15,260.00, a price-to-earnings ratio of 42.57 and a beta of 0.95.

In other Markel news, insider Alan I. Kirshner sold 100 shares of Markel stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $1,133.50, for a total transaction of $113,350.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Steven A. Markel sold 200 shares of Markel stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $1,078.70, for a total value of $215,740.00. Following the sale, the insider now directly owns 108,761 shares of the company’s stock, valued at approximately $117,320,490.70. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,438 shares of company stock valued at $2,691,350. Corporate insiders own 2.53% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Markel (MKL) Share Price” was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at

About Markel

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with's FREE daily email newsletter.